Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Akebia Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference


Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that its President and Chief Executive Officer, John P. Butler, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 9:30 a.m. PT in San Francisco.

A live webcast and replay of Akebia's presentation and associated Q&A will be available on the Company's website at www.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.


These press releases may also interest you

23 avr 2024
Gallium Nitride Semiconductor Devices Market Projected to Reach $33.54 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Gallium Nitride Semiconductor Devices Market (GaN) by Device Type (Opto-semiconductor, Power Semiconductor, RF Semiconductor), Device (Discrete Semiconductor, Integrated Semiconductor), Component, Wafer Size, Voltage Range,...

23 avr 2024
GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Tech Innovator Purba Majumder Recognized as One of North America's Top 100 Women Leaders in 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
Industrial leader Dag J. Opedal elected to be the new Chair of HydrogenPro ASA
The Annual General Meeting and the Extraordinary General Meeting agreed in the nomination committee's proposal. Mr. Dag J. Opedal was therefore elected to become the new Chair of the Board of HydrogenPro ASA. The new board consists primarily of...

23 avr 2024
Glycated Albumin Assay Market Projected to Reach $360.92 million by 2030 - Exclusive Report by 360iResearch
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
SUPCON Unveils Groundbreaking Products in June, Including the World's First UCS
In June, SUPCON (688777) is poised to launch two groundbreaking products in Singapore: the world's first UCS (Universal Control System) and TPT (Time-Series Pre-trained Transformer), the first time-series model in the process industry. UCS, a...

More news about Science and technology...


News published on and distributed by: